176 related articles for article (PubMed ID: 17720299)
1. The antivascular action of physiotherapy ultrasound on a murine tumor: role of a microbubble contrast agent.
Wood AK; Bunte RM; Cohen JD; Tsai JH; Lee WM; Sehgal CM
Ultrasound Med Biol; 2007 Dec; 33(12):1901-10. PubMed ID: 17720299
[TBL] [Abstract][Full Text] [Related]
2. Histopathological observations of the antivascular effects of physiotherapy ultrasound on a murine neoplasm.
Bunte RM; Ansaloni S; Sehgal CM; Lee WM; Wood AK
Ultrasound Med Biol; 2006 Mar; 32(3):453-61. PubMed ID: 16530105
[TBL] [Abstract][Full Text] [Related]
3. The antivascular action of physiotherapy ultrasound on murine tumors.
Wood AK; Ansaloni S; Ziemer LS; Lee WM; Feldman MD; Sehgal CM
Ultrasound Med Biol; 2005 Oct; 31(10):1403-10. PubMed ID: 16223644
[TBL] [Abstract][Full Text] [Related]
4. The disruption of murine tumor neovasculature by low-intensity ultrasound-comparison between 1- and 3-MHz sonication frequencies.
Wood AK; Bunte RM; Price HE; Deitz MS; Tsai JH; Lee WM; Sehgal CM
Acad Radiol; 2008 Sep; 15(9):1133-41. PubMed ID: 18692754
[TBL] [Abstract][Full Text] [Related]
5. Acute increases in murine tumor echogenicity after antivascular ultrasound therapy: a pilot preclinical study.
Wood AK; Bunte RM; Schultz SM; Sehgal CM
J Ultrasound Med; 2009 Jun; 28(6):795-800. PubMed ID: 19470820
[TBL] [Abstract][Full Text] [Related]
6. Dose-response relationship of ultrasound contrast agent in an in vivo murine melanoma model.
Seiler GS; Ziemer LS; Schultz S; Lee WM; Sehgal CM
Cancer Imaging; 2007 Dec; 7(1):216-23. PubMed ID: 18083651
[TBL] [Abstract][Full Text] [Related]
7. Antivascular ultrasound therapy: magnetic resonance imaging validation and activation of the immune response in murine melanoma.
Hunt SJ; Gade T; Soulen MC; Pickup S; Sehgal CM
J Ultrasound Med; 2015 Feb; 34(2):275-87. PubMed ID: 25614401
[TBL] [Abstract][Full Text] [Related]
8. Antivascular ultrasound therapy extends survival of mice with implanted melanomas.
Wood AK; Schultz SM; Lee WM; Bunte RM; Sehgal CM
Ultrasound Med Biol; 2010 May; 36(5):853-7. PubMed ID: 20381952
[TBL] [Abstract][Full Text] [Related]
9. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations.
Gee MS; Saunders HM; Lee JC; Sanzo JF; Jenkins WT; Evans SM; Trinchieri G; Sehgal CM; Feldman MD; Lee WM
Cancer Res; 2001 Apr; 61(7):2974-82. PubMed ID: 11306476
[TBL] [Abstract][Full Text] [Related]
10. Microbubble-enhanced ultrasound for the antivascular treatment and monitoring of hepatocellular carcinoma.
D'Souza JC; Sultan LR; Hunt SJ; Gade TP; Karmacharya MB; Schultz SM; Brice AK; Wood AKW; Sehgal CM
Nanotheranostics; 2019; 3(4):331-341. PubMed ID: 31687321
[No Abstract] [Full Text] [Related]
11. Selective depletion of tumor neovasculature by microbubble destruction with appropriate ultrasound pressure.
Wang J; Zhao Z; Shen S; Zhang C; Guo S; Lu Y; Chen Y; Liao W; Liao Y; Bin J
Int J Cancer; 2015 Nov; 137(10):2478-91. PubMed ID: 25951495
[TBL] [Abstract][Full Text] [Related]
12. Tumor vascularization in experimental melanomas: correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading.
Schroeder RJ; Hauff P; Bartels T; Vogel K; Jeschke J; Hidajat N; Maeurer J
Ultrasound Med Biol; 2001 Jun; 27(6):761-71. PubMed ID: 11516536
[TBL] [Abstract][Full Text] [Related]
13. Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging.
Pysz MA; Foygel K; Panje CM; Needles A; Tian L; Willmann JK
Invest Radiol; 2011 Mar; 46(3):187-95. PubMed ID: 21150790
[TBL] [Abstract][Full Text] [Related]
14. Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results.
Forsberg F; Dicker AP; Thakur ML; Rawool NM; Liu JB; Shi WT; Nazarian LN
Ultrasound Med Biol; 2002 Apr; 28(4):445-51. PubMed ID: 12049957
[TBL] [Abstract][Full Text] [Related]
15. Delta-projection imaging on contrast-enhanced ultrasound to quantify tumor microvasculature and perfusion.
Sehgal CM; Cary TW; Arger PH; Wood AK
Acad Radiol; 2009 Jan; 16(1):71-8. PubMed ID: 19064214
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of high frequency ultrasound methods and contrast agents for characterising tumor response to anti-angiogenic treatment.
Rix A; Lederle W; Siepmann M; Fokong S; Behrendt FF; Bzyl J; Grouls C; Kiessling F; Palmowski M
Eur J Radiol; 2012 Oct; 81(10):2710-6. PubMed ID: 22093958
[TBL] [Abstract][Full Text] [Related]
17. Enhanced heat deposition using ultrasound contrast agent--modeling and experimental observations.
Razansky D; Einziger PD; Adam DR
IEEE Trans Ultrason Ferroelectr Freq Control; 2006 Jan; 53(1):137-47. PubMed ID: 16471440
[TBL] [Abstract][Full Text] [Related]
18. Monitoring angiogenesis in human melanoma xenograft model using contrast-enhanced ultrasound imaging.
Forsberg F; Ro RJ; Liu JB; Lipcan KJ; Potoczek M; Nazarian LN
Ultrason Imaging; 2008 Oct; 30(4):237-46. PubMed ID: 19507677
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-mediated microbubble enhancement of radiation therapy studied using three-dimensional high-frequency power Doppler ultrasound.
Kwok SJ; El Kaffas A; Lai P; Al Mahrouki A; Lee J; Iradji S; Tran WT; Giles A; Czarnota GJ
Ultrasound Med Biol; 2013 Nov; 39(11):1983-90. PubMed ID: 23993051
[TBL] [Abstract][Full Text] [Related]
20. Correlation of quantified contrast-enhanced sonography with in vivo tumor response.
Hwang M; Hariri G; Lyshchik A; Hallahan DE; Fleischer AC
J Ultrasound Med; 2010 Apr; 29(4):597-607. PubMed ID: 20375378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
